Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome

International Journal of Clinical Practice

Volumn 58, Issue 11, 2004, Pages 1003-1007

  Mercanoglu, Fehmi ^a   Erdogan, D ^b   Oflaz, H ^a   Kucukkaya R ^a   Selcukbiricik, F ^a   Gul A ^a   Inanc, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Endothelial functions; Primary anti phospholipid antibody syndrome; Vascular ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; GLYCERYL TRINITRATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING TIME; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE DURATION; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HUMAN; HYPEREMIA; LUNG EMBOLISM; MALE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK FACTOR; STROKE; THROMBOCYTE; VASODILATATION; VEIN THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; NITROGLYCERIN; RISK FACTORS; VASCULAR DISEASES; VASODILATION; VASODILATOR AGENTS;

EID: 10444276554     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00162.x     Document Type: Article

References (29)

1. Hughes GRV, Harris EN, Gharavi A.E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
2. Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol 1990; 17: 733-5.
3. D'Cruz D, Hughes GRV. Antibodies, thrombosis and the endothelium. Br J Rheumatol 1994; 33: 2-4.
4. Del Papa N, Raschi E, Catelli L et al. Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies. Am J Reprod Immunol 1997; 38: 212-7.
5. Pierangeli SS, Colden-Stanfield M, Liu X et al. Antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
6. Williams FM, Parmar K, Hughes GR, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 2000; 84: 742-6.
7. Matsuura E, Kobayashi K, Koike T, Shoenfeld Y. Autoantibody-mediated atherosclerosis. Autoimmunity Rev 2002; 1 348-53.
8. Bowles CA. Vasculopathy associated with the antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1990; 16: 471-90.
9. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105: 546-9.
10. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
11. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
12. Harris EN, Phil M. The second international anti-cardiolipin standardization workshop/The Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-84.
13. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants. An update. Thromb Haemost 1995; 74: 1185-8.
14. Coretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39 257-65.
15. Zhao Y, Rumold R, Zhu M et al. An IgG antiprothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum 1999; 42: 2132-8.
16. Hanly JG, Hong C, Issekutz A. Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells. J Rheumatol 1996; 23: 1543-9.
17. Pierangeli SS, Colden-Stanfield M, Liu X et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
18. Lima DSN, Sato EI, Lima VC et al. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2006-11.
19. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanism in patients with Behçet's syndrome. J Am Coll Cardiol 2001; 37: 517-20.
20. Raza K, Thambyrajah J, Townend JN et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 2000; 102: 1470-2.
21. Shaish A, George J, Afek A et al. Induction of early atherogenesis in LDL-receptor deficient mice immunized with beta2 glycoprotein I. Circulation 1998; 98: 1108-15.
22. Fomero FI, Khamashta MA, Hughes GR. Lipoprotein (a) oxidation and autoantibodies: a new path in atherothrombosis. Lupus 2000; 9: 206-9.
23. George J, Haratz D, Shoenfeld Y. Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. Rheum Dis Clin North Am 2001; 27: 603-10.
24. Atsumi T, Khamashta MA, Andujar C et al. Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol 1998; 25 69-73.
25. Hamstein A, Norberg R, Bjorkholm M et al. Antibodies to cardiolipin in young survivors of myocardial infarction. Lancet 1986; 1: 113-5.
26. De Caterina RD, d'Ascanio A, Mazzone A et al. Prevalance of anticardiolipin antibodies in coronary artery disease. Am J Cardiol 1990; 65: 922-3.
27. Levine SR, Deegan MJ, Futrell N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-9.
28. Bilora F, Boccioletti V, Girolami B et al. Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost 2002; 8: 103-13.
29. Singh K, Gaiha M, Shome DK et al. The association of antiphospholipid antibodies with ischaemic stroke and myocardial infarction in young and their correlation: a preliminary study. J Assoc Physicians India 2001; 49: 527-9.